Table 4.
DS, direct sequencing; EGFR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor; RFLP, restriction fragment length polymorphism.
DS, direct sequencing; EGFR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor; RFLP, restriction fragment length polymorphism.